Vascular endothelial growth factor gene polymorphisms and pregnancy

References

• Ferrara N, Houck K, Jakeman L, Leung D W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18–32
   PubMed Web of Science ®Google Scholar
• Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996; 93: 1493–1495
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–676
   PubMed Web of Science ®Google Scholar
• Harry L E, Paleolog E M. From the cradle to the clinic: VEGF in developmental, physiological, and pathological angiogenesis. Birth Defects Res C Embryo Today 2003; 69: 363–374
   PubMedGoogle Scholar
• Vuorela P, Helske S, Hornig C, Alitalo K, Weich H, Halmesmaki E. Amniotic fluid – soluble vascular endothelial growth factor receptor-1 in preeclampsia. Obstet Gynecol 2000; 95: 353–357
   PubMed Web of Science ®Google Scholar
• Anthony F W, Evans P W, Wheeler T, Wood P J. Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997; 34: 276–280
   PubMed Web of Science ®Google Scholar
• Zygmunt M, Herr F, Munstedt K, Lang U, Liang O D. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003; 110(Suppl. 1)S10–218
   Google Scholar
• te Velde E A, Exalto N, Hesseling P, van der Linden H C. First trimester development of human chorionic villous vascularization studied with CD34 immunohistochemistry. Hum Reprod 1997; 12: 1577–1581
   Google Scholar
• Sharkey A M, Charnock-Jones D S, Boocock C A, Brown K D, Smith S K. Expression of mRNA for vascular endothelial growth factor in human placenta. J Reprod Fertil 1993; 99: 609–615
   PubMedGoogle Scholar
• Geva E, Ginzinger D G, Zaloudek C J, Moore D H, Byrne A, Jaffe R B. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002; 87: 4213–4224
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4–25
   PubMed Web of Science ®Google Scholar
• Dvorak H F, Brown L F, Detmar M, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–1039
   PubMed Web of Science ®Google Scholar
• Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001; 47: 617–623
   PubMed Web of Science ®Google Scholar
• Ahmed A, Li X F, Dunk C, Whittle M J, Rushton D I, Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 1995; 12: 235–243
   PubMed Web of Science ®Google Scholar
• Shiraishi S, Nakagawa K, Kinukawa N, Nakano H, Sueishi K. Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta 1996; 17: 111–121
   PubMed Web of Science ®Google Scholar
• Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico M G, Alitalo K, Halmesmaki E. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997; 56: 489–494
   PubMed Web of Science ®Google Scholar
• Cooper J C, Sharkey A M, McLaren J, Charnock-Jones D S, Smith S K. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J Reprod Fertil 1995; 105: 205–213
   PubMedGoogle Scholar
• Marvin K W, Keelan J A, Eykholt R L, Sato T A, Mitchell M D. Expression of angiogenic and neurotrophic factors in the human amnion and choriodecidua. Am J Obstet Gynecol 2002; 187: 728–734
   PubMed Web of Science ®Google Scholar
• Baker P N, Krasnow J, Roberts J M, Yeo K T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995; 86: 815–821
   PubMed Web of Science ®Google Scholar
• Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200–1204
   PubMed Web of Science ®Google Scholar
• Galazios G, Papazoglou D, Giagloglou K, Vassaras G, Koutlaki N, Maltezos E. Umbilical cord serum vascular endothelial growth factor (VEGF) levels in normal pregnancies and in pregnancies complicated by preterm delivery or pre-eclampsia. Int J Gynaecol Obstet 2004; 85: 6–11
   PubMed Web of Science ®Google Scholar
• Goldberg M A, Schneider T J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 1994; 269: 4355–4359
   PubMed Web of Science ®Google Scholar
• Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, Couffinhal T, Isner J M. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997; 3: 879–886
   PubMed Web of Science ®Google Scholar
• Fernandez-Patron C, Radomski M W, Avidge S T. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 1999; 85: 906–911
   PubMed Web of Science ®Google Scholar
• Arngrimsson R, Bjornsson H, Geirsson R T. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertens Pregnancy 1995; 14: 27–38
   Web of Science ®Google Scholar
• Chesley L C, Cooper D W. Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986; 93: 898–908
   PubMedGoogle Scholar
• Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Invest 1999; 6: 3–10
   PubMedGoogle Scholar
• Papazoglou D, Galazios G, Koukourakis M I, Panagopoulos I, Kontomanolis E N, Papatheodorou K, Maltezos E. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 2004; 10: 321–324
   PubMed Web of Science ®Google Scholar
• Shim J Y, Jun J K, Jung B K, Kim S H, Won H S, Lee P R, Kim A. Vascular endothelial growth factor gene +936C/T polymorphism is associated with preeclampsia in Korean women. Am J Obstet Gynecol 2007; 197: 271–274
   PubMed Web of Science ®Google Scholar
• Kim Y J, Park B H, Park H, Jung S C, Pang M G, Ryu H M, Lee K S, Eom S M, Park H Y. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet 2008; 11: 77–83
   PubMed Web of Science ®Google Scholar
• Kupferminc M J, Daniel Y, Englender T, Baram A, Many A, Jaffa A J, Gull I, Lessing J B. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997; 38: 302–306
   PubMed Web of Science ®Google Scholar
• Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension 2000; 36: 965–969
   PubMed Web of Science ®Google Scholar
• Maynard S E, Min J Y, Merchan J, Lim K H, Li J, Mondal S, Libermann T A, Morgan J P, Sellke F W, Stillman I E, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649–658
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer I A, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1997; 104: 223–228
   PubMedGoogle Scholar
• Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O, Taketani Y. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab 2003; 88: 2348–2351
   PubMed Web of Science ®Google Scholar
• Ranheim T, Staff A C, Henriksen T. VEGF mRNA is unaltered in decidual and placental tissues in preeclampsia at delivery. Acta Obstet Gynecol Scand 2001; 80: 93–98
   PubMed Web of Science ®Google Scholar
• Lachmeijer A M, Dekker G A, Pals G, Aarnoudse J G, ten Kate L P, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105: 94–113
   PubMed Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000; 37: 443–448
   PubMed Web of Science ®Google Scholar
• Livingston J C, Chin R, Haddad B, McKinney E T, Ahokas R, Sibai B M. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000; 183: 1554–1557
   PubMed Web of Science ®Google Scholar
• Madazli R, Aydin S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003; 82: 797–802
   PubMed Web of Science ®Google Scholar
• Galazios G, Papazoglou D, Giagloglou K, Vassaras G, Maltezos E, Anastasiadis P. Interleukin-6 levels in umbilical artery serum in normal and abnormal pregnancies. Int J Gynaecol Obstet 2002; 78: 147–151
   PubMed Web of Science ®Google Scholar
• Polliotti B M, Fry A G, Saller D N, Mooney R A, Cox C, Miller R K. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101: 1266–1274
   PubMed Web of Science ®Google Scholar
• Romero R, Avila C, Santhanam U, Sehgal P B. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Invest 1990; 85: 1392–1400
   PubMed Web of Science ®Google Scholar
• Ong S, Lash G, Baker P N. Angiogenesis and placental growth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 969–980
   PubMed Web of Science ®Google Scholar
• Silver R M, Schwinzer B, McGregor J A. Interleukin-6 levels in amniotic fluid in normal and abnormal pregnancies: preeclampsia, small-for-gestational-age fetus, and premature labor. Am J Obstet Gynecol 1993; 169: 1101–1105
   PubMed Web of Science ®Google Scholar
• Carlini L, Somigliana E, Rossi G, Veglia F, Busacca M, Vignali M. Risk factors for spontaneous preterm birth: a Northern Italian multicenter case-control study. Gynecol Obstet Invest 2002; 53: 174–180
   PubMed Web of Science ®Google Scholar
• Fedrick J, Anderson A B. Factors associated with spontaneous pre-term birth. Br J Obstet Gynaecol 1976; 83: 342–350
   PubMedGoogle Scholar
• Aveyard P, Cheng K K, Manaseki S, Gardosi J. The risk of preterm delivery in women from different ethnic groups. BJOG 2002; 109: 894–899
   PubMed Web of Science ®Google Scholar
• Migone A, Emanuel I, Mueller B, Daling J, Little R E. Gestational duration and birthweight in white, black and mixed-race babies. Paediatr Perinat Epidemiol 1991; 5: 378–391
   PubMedGoogle Scholar
• Rudnik-Schoneborn S, Nicholson G A, Morgan G, Rohrig D, Zerres K. Different patterns of obstetric complications in myotonic dystrophy in relation to the disease status of the fetus. Am J Med Genet 1998; 80: 314–321
   PubMedGoogle Scholar
• Brown K R, England K M, Goss K L, Snyder J M, Acarregui M J. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1001–L1010
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder R M, Taraseviciene-Stewart L, Le Cras T D, Abman S, Hirth P K, Waltenberger J, Voelkel N F. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311–1319
   PubMed Web of Science ®Google Scholar
• Papazoglou D, Galazios G, Koukourakis M I, Kontomanolis E N, Maltezos E. Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet Gynecol Scand 2004; 83: 461–465
   PubMed Web of Science ®Google Scholar
• Watson C J, Webb N J, Bottomley M J, Brenchley P E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000; 12: 1232–1235
   PubMed Web of Science ®Google Scholar
• Regan L. Overview of recurrent miscarriage. Gynaecol Forum 1998; 3: 3–7
   Google Scholar
• Li T C, Makris M, Tomsu M, Tuckerman E, Laird S. Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update 2002; 8: 463–481
   PubMed Web of Science ®Google Scholar
• Wilcox A J, Weinberg C R, O'Connor J F, Baird D D, Schlatterer J P, Canfield R E, Armstrong E G, Nisula B C. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189–194
   PubMed Web of Science ®Google Scholar
• Vuorela P, Carpen O, Tulppala M, Halmesmaki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 2000; 6: 276–282
   PubMed Web of Science ®Google Scholar
• Meegdes B H, Ingenhoes R, Peeters L L, Exalto N. Early pregnancy wastage: relationship between chorionic vascularization and embryonic development. Fertil Steril 1988; 49: 216–220
   PubMed Web of Science ®Google Scholar
• Vailhe B, Dietl J, Kapp M, Toth B, Arck P. Increased blood vessel density in decidua parietalis is associated with spontaneous human first trimester abortion. Hum Reprod 1999; 14: 1628–1634
   PubMed Web of Science ®Google Scholar
• Papazoglou D, Galazios G, Papatheodorou K, Liberis V, Papanas N, Maltezos E, Maroulis G B. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil Steril 2005; 83: 959–963
   PubMed Web of Science ®Google Scholar
• Coulam C B, Jeyendran R S. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am J Reprod Immunol 2008; 59: 301–305
   Google Scholar
• Goodman C, Jeyendran R S, Coulam C B. Vascular endothelial growth factor gene polymorphism and implantation failure. Reprod Biomed Online 2008; 16: 720–723
   Google Scholar
• Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–439
   PubMed Web of Science ®Google Scholar
• Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea K S, Powell-Braxton L, Hillan K J, Moore M W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–442
   PubMed Web of Science ®Google Scholar
• Laudenbach V, Fontaine R H, Medja F, Carmeliet P, Hicklin D J, Gallego J, Leroux P, Marret S, Gressens P. Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis 2007; 26: 243–252
   PubMed Web of Science ®Google Scholar
• Sivakumar V, Lu J, Ling E A, Kaur C. Vascular endothelial growth factor and nitric oxide production in response to hypoxia in the choroid plexus in neonatal brain. Brain Pathol 2008; 18: 71–85
   PubMed Web of Science ®Google Scholar
• Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, et al. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8: 702–710
   PubMed Web of Science ®Google Scholar
• Spalding S J, Hennon T, Dohar J, Arkachaisri T. Neonatal lupus erythematosus complicated by mucocutaneous and visceral hemangiomas. Lupus 2007; 16: 904–907
   Google Scholar